CUSTOM ANTIBODY SERVICE MARKET ANALYSIS

Market Challenges And Opportunities

Global Custom Antibody Service Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe. The coronavirus (COVID 19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. Supply chain and manufacturing activities have been disrupted globally, due to lockdowns implemented by governments of countries, restricted movement, and other COVID-19 safety precautions.

Identifying individuals infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a focal point throughout the coronavirus disease (COVID-19) pandemic. This has thus created a public health need for COVID-19 testing that is timely, reliable, and widely available.

Market players and academic or research institutes  are engaged in research and development activities for treatment of COVID-19 and due to this there has been increase in custom antibody services for COVID-19. This is expected to positively impact growth of the global custom antibody service market during the COVID-19 pandemic.

Global Custom Antibody Service Market: Restraint

Challenges involved in the production of customized antibodies is the major factor hampering the growth of the custom antibody services market. Some challenges includes:

• Low yield: In vitro production cultures often yield less antibody/ml than in vivo ascitic fluid method
• Cell death: Maintaining optimal cell growth and viability is essential for high antibody yields and an optimized process
• Contamination: In vitro production cultures are subject to risks of contamination associated with long-term cell cultures
• Time-consuming: In vitro production cultures often have to be maintained over a long period of time in order to yield desired quantities of antibodies